You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

List of Excipients in API quinapril hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing quinapril hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Parke-Davis Div of Pfizer Inc ACCUPRIL quinapril hydrochloride 0071-0527 CANDELILLA WAX
Parke-Davis Div of Pfizer Inc ACCUPRIL quinapril hydrochloride 0071-0527 CROSPOVIDONE
Parke-Davis Div of Pfizer Inc ACCUPRIL quinapril hydrochloride 0071-0527 FERRIC OXIDE RED
Parke-Davis Div of Pfizer Inc ACCUPRIL quinapril hydrochloride 0071-0527 GELATIN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing quinapril hydrochloride

Company Ingredient NDC Excipient
A-S Medication Solutions quinapril hydrochloride 50090-2116 CROSPOVIDONE
A-S Medication Solutions quinapril hydrochloride 50090-2116 FERRIC OXIDE RED
A-S Medication Solutions quinapril hydrochloride 50090-2116 HYDROXYPROPYL CELLULOSE
A-S Medication Solutions quinapril hydrochloride 50090-2116 HYPROMELLOSE 2910
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for quinapril hydrochloride

Excipient focus: CANDELILLA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

quinapril hydrochloride drug variants containing FERRIC OXIDE YELLOW

Company Ingredient NDC
Parke-Davis Div of Pfizer Inc quinapril hydrochloride and hydrochlorothiazide 0071-0222
Parke-Davis Div of Pfizer Inc quinapril hydrochloride and hydrochlorothiazide 0071-0223
Greenstone LLC quinapril hydrochloride and hydrochlorothiazide 59762-0222
Lake Erie Medical DBA Quality Care Products LLC quinapril hydrochloride/hydrochlorothiazide 35356-998
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM CARBONATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

quinapril hydrochloride drug variants containing POVIDONE

Company Ingredient NDC
Parke-Davis Div of Pfizer Inc quinapril hydrochloride and hydrochlorothiazide 0071-0222
Parke-Davis Div of Pfizer Inc quinapril hydrochloride and hydrochlorothiazide 0071-0223
Camber Pharmaceuticals quinapril hydrochloride and hydrochlorothiazide 31722-374
Physicians Total Care Inc quinapril hydrochloride and hydrochlorothiazide 54868-1802
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: SILICON DIOXIDE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links